Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.

Mah V, Marquez D, Alavi M, Maresh EL, Zhang L, Yoon N, Horvath S, Bagryanova L, Fishbein MC, Chia D, Pietras R, Goodglick L. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer. 2011 Nov; 74(2):318-25.

View in: PubMed

subject areas

Aged
Aromatase
Carcinoma, Non-Small-Cell Lung
Estrogen Receptor beta
Female
Humans
Immunohistochemistry
Lung Neoplasms
Male
Microarray Analysis
Middle Aged
Predictive Value of Tests
Prognosis
Smoking
Survival Analysis

authors with profiles

Richard J. Pietras, MD, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support